Retraction Note to: Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice (Journal of Natural Medicines, (2012), 66, 4, (591-599), 10.1007/s11418-011-0623-x);Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice

Journal of Natural Medicines

Volumn 66, Issue 4, 2012, Pages 591-599

  Harada, Shinichi ^a   Kishimoto, Maya ^a   Kobayashi, Mana ^a   Nakamoto, Kazuo ^a   Wakako, Fujita Hamabe ^a   Chen, Hwei Hsien ^b   Chan, Ming Huan ^b   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

5' AMP activated protein kinase; Glucose intolerance; Honokiol; Infarction; Middle cerebral artery occlusion; Phosphoenolpyruvate carboxykinase

Indexed keywords

ADIPONECTIN; GLUCOSE; HONOKIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PHOSPHOPYRUVATE CARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE INDEX; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MEMORY DISORDER; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVE INJURY; NEURONAL DAMAGE; NEUROPROTECTION; NONHUMAN; POST ISCHEMIA GLUCOSE INTOLERANCE; PROTEIN EXPRESSION;

EID: 84863470109     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-020-01392-y     Document Type: Erratum

References (38)

1. World Health Organization (2000) Guidelines for the regulatory assessment of medicinal products for use in self-medication. WHO, Geneva
2. Suzuki N (2008) Clinical application of dietary supplements. Nippon Yakurigaku Zasshi 131:252-257 (Pubitemid 351914453)
3. Fujita M, Itokawa H, Sashida Y (1973) Studies on the components of Magnolia obovata Thunb. 3. Occurrence of magnolol and honokiol in M. obovata and other allied plants. Yakugaku Zasshi 93:429-434
4. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK (2003) Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 992:159-166
5. Irie T, Miyamoto E, Kitagawa K, Maruyama Y, Inoue K, Inagaki C (2001) An anxiolytic agent, dihydrohonokiol-B, inhibits ammonia-induced increases in the intracellular Cl(-) of cultured rat hippocampal neurons via GABA(c) receptors. Neurosci Lett 312:121-123 (Pubitemid 32938243)
6. Liu B, Hattori N, Zhang NY, Wu B, Yang L, Kitagawa K, Xiong ZM, Irie T, Inagaki C (2005) Anxiolytic agent, dihydrohonokiol- B, recovers amyloid beta protein-induced neurotoxicity in cultured rat hippocampal neurons. Neurosci Lett 384:44-47 (Pubitemid 40826615)
7. Lin YR, Chen HH, Ko CH, Chan MH (2005) Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures. Neuropharmacology 49:542-550
8. Fukuyama Y, Nakade K, Minoshima Y, Yokoyama R, Zhai H, Mitsumoto Y (2002) Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons. Bioorg Med Chem Lett 12:1163-1166 (Pubitemid 34270554)
9. Zhai H, Nakade K, Oda M, Mitsumoto Y, Akagi M, Sakurai J, Fukuyama Y (2005) Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2). Eur J Pharmacol 516:112-117 (Pubitemid 40799346)
10. Chen CM, Liu SH, Lin-Shiau SY (2007) Honokiol, a neuroprotectant against mouse cerebral ischaemia, mediated by preserving Na+, K+-ATPase activity and mitochondrial functions. Basic Clin Pharmacol Toxicol 101:108-116
11. Kagansky N, Levy S, Knobler H (2001) The role of hyperglycemia in acute stroke. Arch Neurol 58:1209-1212 (Pubitemid 32751739)
12. Toni D, De Michele M, Fiorelli M, Bastianello S, Camerlingo M, Sacchetti ML, Argentino C, Fieschi C (1994) Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion. J Neurol Sci 123:129-133 (Pubitemid 24167438)
13. Ennis SR, Keep RF (2007) Effect of sustained-mild and transientsevere hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab 27:1573-1582 (Pubitemid 47301440)
14. Folbergrova J, Memezawa H, Smith ML, Siesjo BK (1992) Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab 12:25-33
15. Berger L, Hakim AM (1986) The association of hyperglycemia with cerebral edema in stroke. Stroke 17:865-871 (Pubitemid 16000719)
16. Widmer H, Abiko H, Faden AI, James TL, Weinstein PR (1992) Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1H and 31P NMR spectroscopy with fatty acid and excitatory amino acid levels. J Cereb Blood Flow Metab 12:456-468
17. Dietrich WD, Alonso O, Busto R (1993) Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24:111-116 (Pubitemid 23014392)
18. Harada S, Fujita WH, Shichi K, Tokuyama S (2009) The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 1279:174-181
19. Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25 (Pubitemid 43960587)
20. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109(Suppl 1):17-23
21. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ (1998) Evidence for 50 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373 (Pubitemid 28357021)
22. Merrill GF, Kurth EJ, Hardie DG, Winder WW (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273:E1107-E1112
23. Choi SS, Cha BY, Iida K, Sato M, Lee YS, Teruya T, Yonezawa T, Nagai K, Woo JT (2011) Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes. J Nat Med 65:424-430
24. Alonso-Castro AJ, Zapata-Bustos R, Dominguez F, Garcia- Carranca A, Salazar-Olivo LA (2011) Magnolia dealbata Zucc and its active principles honokiol and magnolol stimulate glucose uptake in murine and human adipocytes using the insulin-signaling pathway. Phytomedicine 18:926-933
25. Harada S, Hamabe W, Kamiya K, Satake T, Yamamoto J, Tokuyama S (2009) Preventive effect of Morinda citrifolia fruit juice on neuronal damage induced by focal ischemia. Biol Pharm Bull 32:405-409
26. Shichi K, Fujita-Hamabe W, Harada S, Mizoguchi H, Yamada K, Nabeshima T, Tokuyama S (2011) Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. J Pharmacol Exp Ther 338:701-710
27. Harada S, Fujita-Hamabe W, Tokuyama S (2010) The importance of regulation of blood glucose levels through activation of peripheral 50-AMP-activated protein kinase on ischemic neuronal damage. Brain Res 1351:254-263
28. Harada S, Fujita-Hamabe W, Tokuyama S (2011) Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J Pharmacol Sci 115:155-163
29. Hall ED, Braughler JM (1989) Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 6:303-313 (Pubitemid 19076496)
30. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J (1978) Free radicals in cerebral ischemia. Stroke 9:445-447 (Pubitemid 8389070)
31. Kitagawa K, Matsumoto M, Oda T, Niinobe M, Hata R, Handa N, Fukunaga R, Isaka Y, Kimura K, Maeda H et al (1990) Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience 35:551-558 (Pubitemid 20198389)
32. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295 (Pubitemid 35373562)
33. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, Downes M, Evans RM, Montminy M, Shaw RJ (2011) Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145:607-621
34. Chiu JH, Ho CT, Wei YH, Lui WY, Hong CY (1997) In vitro and in vivo protective effect of honokiol on rat liver from peroxidative injury. Life Sci 61:1961-1971
35. Taira J, Ikemoto T, Mimura K, Hagi A, Murakami A, Makino K (1993) Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds. Free Radic Res Commun 19(Suppl 1):S71-S77 (Pubitemid 24024892)
36. Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen YP, Hsu HY (1988) Two antiplatelet agents from Magnolia officinalis. Thromb Res 50:757-765
37. Lo YC, Teng CM, Chen CF, Chen CC, Hong CY (1994) Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol 47:549-553
38. Son HJ, Lee HJ, Yun-Choi HS, Ryu JH (2000) Inhibitors of nitric oxide synthesis and TNF-αlpha expression from Magnolia obovata in activated macrophages. Planta Med 66:469-471 (Pubitemid 30413511)